Ethacrynic acid alone and in combination with methyldopa in the management of mild hypertension. A report of 23 patients.
D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004357:Drug Synergism; D004976:Ethacrynic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D005260:Female; D005414:Flatulence / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use*; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D011188:Potassium / Q000097:blood; D013649:Taste / Q000187:drug effects; D014508:Urea / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014839:Vomiting / Q000139:chemically induced
D014527:Uric Acid; D008750:Methyldopa; D014508:Urea; D004976:Ethacrynic Acid; D011188:Potassium